Targeted Gene Knock-Out of Fel d1 in Fetal Fibroblasts Using CRISPR-Cas9: Implications for Cat Allergies
- PMID: 40218321
- PMCID: PMC11987803
- DOI: 10.3390/ani15070927
Targeted Gene Knock-Out of Fel d1 in Fetal Fibroblasts Using CRISPR-Cas9: Implications for Cat Allergies
Abstract
Fel d1 is the most important allergen secreted by cats, which can trigger asthma in sensitive individuals. Our objective was to knock-out the Fel d1 gene in the fetal fibroblasts of cats through CRISPR-Cas9 technology with two sgRNAs and to determine the impact of such mutations on the antigenicity of the Fel d1 protein. DNA samples from 38 domestic cats were collected and amplified by PCR to obtain the complete sequence of the Fel d1 gene. Throughout evolution, Fel d1 polypeptide chain 1(CH1) has proven to be much more conserved than Fel d1 polypeptide chain 2(CH2); therefore, we targeted CH2 and designed two single-guide RNAs (CH2-sgRNA-1 and CH2-sgRNA-2) for this region. Using these constructed sgRNAs, we performed gene knock-out in fetal fibroblasts, resulting in two mutations within the target gene. Following this, DNA was extracted and the target site product was cloned using TA cloning via PCR, and a single colony from this process was sequenced to analyze the physicochemical properties, antigenic sites, and three-dimensional structure of the mutated protein. The results revealed that there were 12 and 51 polymorphic loci (single-nucleotide polymorphisms, or SNPs) found in the CH1 and CH2 sequences, respectively, with most loci located in the GC-rich intron 2, while others were found in exon 2, intron 3, and exon 3. These SNPs guided sgRNA design by identifying conserved regions in the CH2 gene. The gene editing efficiency for the CH2 region, with this dual CRISPR system, was 40%, with 35% attributed to Type 1 mutation and 5% to Type 2 mutation. In conclusion, CH1 is significantly more conserved than CH2, and the antigenicity of the Fel d1 CH2 gene in domestic cats can be effectively reduced through CRISPR-Cas9 gene editing.
Keywords: CRISPR–Cas9; Fel d1; cat; gene knock-out; polymorphism.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures








Similar articles
-
Generation of Fel d 1 chain 2 genome-edited cats by CRISPR-Cas9 system.Sci Rep. 2024 Feb 29;14(1):4987. doi: 10.1038/s41598-024-55464-0. Sci Rep. 2024. PMID: 38424152 Free PMC article.
-
Evolutionary Biology and Gene Editing of Cat Allergen, Fel d 1.CRISPR J. 2022 Apr;5(2):213-223. doi: 10.1089/crispr.2021.0101. Epub 2022 Mar 28. CRISPR J. 2022. PMID: 35343817
-
Genetic diversity of the major cat allergen, Fel d 1.PNAS Nexus. 2024 Nov 26;3(11):pgae447. doi: 10.1093/pnasnexus/pgae447. eCollection 2024 Nov. PNAS Nexus. 2024. PMID: 39600803 Free PMC article.
-
Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer.Narra J. 2024 Dec;4(3):e1177. doi: 10.52225/narra.v4i3.1177. Epub 2024 Nov 16. Narra J. 2024. PMID: 39816115 Free PMC article.
-
Polymorphism Analysis of Ch1 and Ch2 Genes in the Siberian Cat.Vet Sci. 2017 Dec 1;4(4):63. doi: 10.3390/vetsci4040063. Vet Sci. 2017. PMID: 29194349 Free PMC article.
Cited by
-
Review of Toxoplasmosis: What We Still Need to Do.Vet Sci. 2025 Aug 18;12(8):772. doi: 10.3390/vetsci12080772. Vet Sci. 2025. PMID: 40872723 Free PMC article. Review.
References
-
- Morgenstern J.P., Griffith I.J., Brauer A.W., Rogers B.L., Bond J.F., Chapman M.D., Kuo M.-C. Amino Acid Sequence of Fel d 1, the Major Allergen of the Domestic Cat: Protein Sequence Analysis and cDNA Cloning. Proc. Natl. Acad. Sci. USA. 1991;88:9690–9694. doi: 10.1073/pnas.88.21.9690. - DOI - PMC - PubMed
-
- Riabova K., Karsonova A.V., van Hage M., Käck U., Konradsen J.R., Grönlund H., Fomina D., Beltyukov E., Glazkova P.A., Semenov D.Y., et al. Molecular Allergen-Specific IgE Recognition Profiles and Cumulative Specific IgE Levels Associated with Phenotypes of Cat Allergy. Int. J. Mol. Sci. 2022;23:6984. doi: 10.3390/ijms23136984. - DOI - PMC - PubMed
-
- Niespodziana K., Focke-Tejkl M., Linhart B., Civaj V., Blatt K., Valent P., van Hage M., Grönlund H., Valenta R. A Hypoallergenic Cat Vaccine Based on Fel d 1–Derived Peptides Fused to Hepatitis B PreS. J. Allergy Clin. Immunol. 2011;127:1562–1570.e6. doi: 10.1016/j.jaci.2011.02.004. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous